Johnson & Johnson vs Under Armour Inc Class A — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: Johnson & Johnson is far larger — about 195.1× Under Armour Inc Class A's market cap, and Johnson & Johnson pays a 2.15% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| JNJ | UA | |
|---|---|---|
Market Cap | $598.96B | $3.07B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $7.88 |
52-Week Low | $164.36 | $3.96 |
Enterprise Value | $631.90B | $4.70B |
Dividend Yield | 2.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →